Abstract
Background: Low back pain is highly prevalent and the main cause of years lived with disability (YLDs). We present the most up-to-date global, regional, and national data on prevalence and YLDs for low back pain from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Methods: Population-based studies from 1980 to 2019 identified in a systematic review, international surveys, US medical claims data, and dataset contributions by collaborators were used to estimate the prevalence and YLDs for low back pain from 1990 to 2020, for 204 countries and territories. Low back pain was defined as pain between the 12th ribs and the gluteal folds that lasted a day or more; input data using alternative definitions were adjusted in a network meta-regression analysis. Nested Bayesian meta-regression models were used to estimate prevalence and YLDs by age, sex, year, and location. Prevalence was projected to 2050 by running a regression on prevalence rates using Socio-demographic Index as a predictor, then multiplying them by projected population estimates. Findings: In 2020, low back pain affected 619 million (95% uncertainty interval 554–694) people globally, with a projection of 843 million (759–933) prevalent cases by 2050. In 2020, the global age-standardised rate of YLDs was 832 per 100 000 (578–1070). Between 1990 and 2020, age-standardised rates of prevalence and YLDs decreased by 10·4% (10·9–10·0) and 10·5% (11·1–10·0), respectively. A total of 38·8% (28·7–47·0) of YLDs were attributed to occupational factors, smoking, and high BMI. Interpretation: Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased modestly over the past three decades, it is projected that globally in 2050, more than 800 million people will have low back pain. Challenges persist in obtaining primary country-level data on low back pain, and there is an urgent need for more high-quality, primary, country-level data on both prevalence and severity distributions to improve accuracy and monitor change. Funding: Bill and Melinda Gates Foundation.
Original language | English |
---|---|
Pages (from-to) | e316-e329 |
Journal | The Lancet Rheumatology |
Volume | 5 |
Issue number | 6 |
DOIs | |
Publication status | Published - Jun 2023 |
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: The Lancet Rheumatology, Vol. 5, No. 6, 06.2023, p. e316-e329.
Research output: Contribution to journal › Article › peer-review
TY - JOUR
T1 - Global, regional, and national burden of low back pain, 1990–2020, its attributable risk factors, and projections to 2050
T2 - a systematic analysis of the Global Burden of Disease Study 2021
AU - GBD 2021 Low Back Pain Collaborators
AU - Ferreira, Manuela L.
AU - de Luca, Katie
AU - Haile, Lydia M.
AU - Steinmetz, Jaimie D.
AU - Culbreth, Garland T.
AU - Cross, Marita
AU - Kopec, Jacek A.
AU - Ferreira, Paulo H.
AU - Blyth, Fiona M.
AU - Buchbinder, Rachelle
AU - Hartvigsen, Jan
AU - Wu, Ai Min
AU - Safiri, Saeid
AU - Woolf, Anthony D.
AU - Collins, Gary S.
AU - Ong, Kanyin Liane
AU - Vollset, Stein Emil
AU - Smith, Amanda E.
AU - Cruz, Jessica A.
AU - Fukutaki, Kai Glenn
AU - Abate, Semagn Mekonnen
AU - Abbasifard, Mitra
AU - Abbasi-Kangevari, Mohsen
AU - Abbasi-Kangevari, Zeinab
AU - Abdelalim, Ahmed
AU - Abedi, Aidin
AU - Abidi, Hassan
AU - Adnani, Qorinah Estiningtyas Sakilah
AU - Ahmadi, Ali
AU - Akinyemi, Rufus Olusola
AU - Alamer, Abayneh Tadesse
AU - Alem, Adugnaw Zeleke
AU - Alimohamadi, Yousef
AU - Alshehri, Mansour Abdullah
AU - Alshehri, Mohammed Mansour
AU - Alzahrani, Hosam
AU - Amini, Saeed
AU - Amiri, Sohrab
AU - Amu, Hubert
AU - Andrei, Catalina Liliana
AU - Andrei, Tudorel
AU - Antony, Benny
AU - Arabloo, Jalal
AU - Arulappan, Judie
AU - Arumugam, Ashokan
AU - Ashraf, Tahira
AU - Athari, Seyyed Shamsadin
AU - Awoke, Nefsu
AU - Azadnajafabad, Sina
AU - Bärnighausen, Till Winfried
AU - Barrero, Lope H.
AU - Barrow, Amadou
AU - Barzegar, Akbar
AU - Bearne, Lindsay M.
AU - Bensenor, Isabela M.
AU - Berhie, Alemshet Yirga
AU - Bhandari, Bharti Bhandari
AU - Bhojaraja, Vijayalakshmi S.
AU - Bijani, Ali
AU - Bodicha, Belay Boda Abule
AU - Bolla, Srinivasa Rao
AU - Brazo-Sayavera, Javier
AU - Briggs, Andrew M.
AU - Cao, Chao
AU - Charalampous, Periklis
AU - Chattu, Vijay Kumar
AU - Cicuttini, Flavia M.
AU - Clarsen, Benjamin
AU - Cuschieri, Sarah
AU - Dadras, Omid
AU - Dai, Xiaochen
AU - Dandona, Lalit
AU - Dandona, Rakhi
AU - Dehghan, Azizallah
AU - Demie, Takele Gezahegn G.
AU - Denova-Gutiérrez, Edgar
AU - Dewan, Syed Masudur Rahman
AU - Dharmaratne, Samath Dhamminda
AU - Dhimal, Mandira Lamichhane
AU - Dhimal, Meghnath
AU - Diaz, Daniel
AU - Didehdar, Mojtaba
AU - Digesa, Lankamo Ena
AU - Diress, Mengistie
AU - Do, Hoa Thi
AU - Doan, Linh Phuong
AU - Ekholuenetale, Michael
AU - Elhadi, Muhammed
AU - Eskandarieh, Sharareh
AU - Faghani, Shahriar
AU - Fares, Jawad
AU - Fatehizadeh, Ali
AU - Fetensa, Getahun
AU - Filip, Irina
AU - Fischer, Florian
AU - Franklin, Richard Charles
AU - Ganesan, Balasankar
AU - Gemeda, Belete Negese Belete
AU - Getachew, Motuma Erena
AU - Ghashghaee, Ahmad
AU - Gill, Tiffany K.
AU - Golechha, Mahaveer
AU - Goleij, Pouya
AU - Gupta, Bhawna
AU - Hafezi-Nejad, Nima
AU - Haj-Mirzaian, Arvin
AU - Hamal, Pawan Kumar
AU - Hanif, Asif
AU - Harlianto, Netanja I.
AU - Hasani, Hamidreza
AU - Hay, Simon I.
AU - Hebert, Jeffrey J.
AU - Heidari, Golnaz
AU - Heidari, Mohammad
AU - Heidari-Soureshjani, Reza
AU - Hlongwa, Mbuzeleni Mbuzeleni
AU - Hosseini, Mohammad Salar
AU - Hsiao, Alexander Kevin
AU - Iavicoli, Ivo
AU - Ibitoye, Segun Emmanuel
AU - Ilic, Irena M.
AU - Ilic, Milena D.
AU - Islam, Sheikh Mohammed Shariful
AU - Janodia, Manthan Dilipkumar
AU - Jha, Ravi Prakash
AU - Jindal, Har Ashish
AU - Jonas, Jost B.
AU - Kabito, Gebisa Guyasa
AU - Kandel, Himal
AU - Kaur, Rimple Jeet
AU - Keshri, Vikash Ranjan
AU - Khader, Yousef Saleh
AU - Khan, Ejaz Ahmad
AU - Khan, Md Jobair
AU - Khan, Moien AB
AU - Khayat Kashani, Hamid Reza
AU - Khubchandani, Jagdish
AU - Kim, Yun Jin
AU - Kisa, Adnan
AU - Klugarová, Jitka
AU - Kolahi, Ali Asghar
AU - Koohestani, Hamid Reza
AU - Koyanagi, Ai
AU - Kumar, G. Anil
AU - Kumar, Narinder
AU - Lallukka, Tea
AU - Lasrado, Savita
AU - Lee, Wei Chen
AU - Lee, Yo Han
AU - Mahmoodpoor, Ata
AU - Malagón-Rojas, Jeadran N.
AU - Malekpour, Mohammad Reza
AU - Malekzadeh, Reza
AU - Malih, Narges
AU - Mehndiratta, Man Mohan
AU - Mehrabi Nasab, Entezar
AU - Menezes, Ritesh G.
AU - Mentis, Alexios Fotios A.
AU - Mesregah, Mohamed Kamal
AU - Miller, Ted R.
AU - Mirza-Aghazadeh-Attari, Mohammad
AU - Mobarakabadi, Maryam
AU - Mohammad, Yousef
AU - Mohammadi, Esmaeil
AU - Mohammed, Shafiu
AU - Mokdad, Ali H.
AU - Momtazmanesh, Sara
AU - Monasta, Lorenzo
AU - Moni, Mohammad Ali
AU - Mostafavi, Ebrahim
AU - Murray, Christopher J.L.
AU - Nair, Tapas Sadasivan
AU - Nazari, Javad
AU - Nejadghaderi, Seyed Aria
AU - Neupane, Subas
AU - Neupane Kandel, Sandhya
AU - Nguyen, Cuong Tat
AU - Nowroozi, Ali
AU - Okati-Aliabad, Hassan
AU - Omer, Emad
AU - Oulhaj, Abderrahim
AU - Owolabi, Mayowa O.
AU - Panda-Jonas, Songhomitra
AU - Pandey, Anamika
AU - Park, Eun Kee
AU - Pawar, Shrikant
AU - Pedersini, Paolo
AU - Pereira, Jeevan
AU - Peres, Mario F.P.
AU - Petcu, Ionela Roxana
AU - Pourahmadi, Mohammadreza
AU - Radfar, Amir
AU - Rahimi-Dehgolan, Shahram
AU - Rahimi-Movaghar, Vafa
AU - Rahman, Mosiur
AU - Rahmani, Amir Masoud
AU - Rajai, Nazanin
AU - Rao, Chythra R.
AU - Rashedi, Vahid
AU - Rashidi, Mohammad Mahdi
AU - Ratan, Zubair Ahmed
AU - Rawaf, David Laith
AU - Rawaf, Salman
AU - Renzaho, Andre M.N.
AU - Rezaei, Negar
AU - Rezaei, Zahed
AU - Roever, Leonardo
AU - Ruela, Guilherme de Andrade
AU - Saddik, Basema
AU - Sahebkar, Amirhossein
AU - Salehi, Sana
AU - Sanmarchi, Francesco
AU - Sepanlou, Sadaf G.
AU - Shahabi, Saeed
AU - Shahrokhi, Shayan
AU - Shaker, Elaheh
AU - Shamsi, Mohammad Bagher
AU - Shannawaz, Mohammed
AU - Sharma, Saurab
AU - Shaygan, Maryam
AU - Sheikhi, Rahim Ali
AU - Shetty, Jeevan K.
AU - Shiri, Rahman
AU - Shivalli, Siddharudha
AU - Shobeiri, Parnian
AU - Sibhat, Migbar Mekonnen
AU - Singh, Ambrish
AU - Singh, Jasvinder A.
AU - Slater, Helen
AU - Solmi, Marco
AU - Somayaji, Ranjani
AU - Tan, Ker Kan
AU - Thapar, Rekha
AU - Tohidast, Seyed Abolfazl
AU - Valadan Tahbaz, Sahel
AU - Valizadeh, Rohollah
AU - Vasankari, Tommi Juhani
AU - Venketasubramanian, Narayanaswamy
AU - Vlassov, Vasily
AU - Vo, Bay
AU - Wang, Yuan Pang
AU - Wiangkham, Taweewat
AU - Yadav, Lalit
AU - Yadollahpour, Ali
AU - Yahyazadeh Jabbari, Seyed Hossein
AU - Yang, Lin
AU - Yazdanpanah, Fereshteh
AU - Yonemoto, Naohiro
AU - Younis, Mustafa Z.
AU - Zare, Iman
N1 - Funding Information: T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. R Buchbinder is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Fellowship. M Cross acknowledges support from Global Alliance for Musculoskeletal Health. A Fatehizadeh acknowledges support from the Department of Environmental Health Engineering of Isfahan University of Medical Sciences, Isfahan, Iran. S M S Islam is funded by the National Health and Medical Research Council of Australia (NHMRC) and has received funding from the National Heart Foundation of Australia. H Kandel is a Kornhauser Research Fellow at The University of Sydney. J Khubchandani has received funding from TEVA Pharmaceuticals for Migraine related research. Y J Kim was supported by Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). T Lallukka is supported by the Academy of Finland (Grant #330527) and the Social Insurance Institution of Finland (grant 29/26/2020). L Monasta was supported by the Italian Ministry of Health, through a contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy. P Pedersini was supported and funded by the Italian Ministry of Health - Ricerca Corrente 2021. S Sharma is supported by the International Association for the Study of Pain John J Monica Postdoctoral Fellowship. A Singh is supported by International Graduate Research Scholarship, University of Tasmania. Funding Information: T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. R Buchbinder is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Fellowship. M Cross acknowledges support from Global Alliance for Musculoskeletal Health. A Fatehizadeh acknowledges support from the Department of Environmental Health Engineering of Isfahan University of Medical Sciences, Isfahan, Iran. S M S Islam is funded by the National Health and Medical Research Council of Australia (NHMRC) and has received funding from the National Heart Foundation of Australia. H Kandel is a Kornhauser Research Fellow at The University of Sydney. J Khubchandani has received funding from TEVA Pharmaceuticals for Migraine related research. Y J Kim was supported by Research Management Centre, Xiamen University Malaysia (XMUMRF/2020-C6/ITCM/0004). T Lallukka is supported by the Academy of Finland (Grant #330527) and the Social Insurance Institution of Finland (grant 29/26/2020). L Monasta was supported by the Italian Ministry of Health, through a contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy. P Pedersini was supported and funded by the Italian Ministry of Health - Ricerca Corrente 2021. S Sharma is supported by the International Association for the Study of Pain John J Monica Postdoctoral Fellowship. A Singh is supported by International Graduate Research Scholarship, University of Tasmania. Editorial note: The Lancet Group takes a neutral position with respect to territorial claims in published maps and institutional affiliations. Publisher Copyright: © 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2023/6
Y1 - 2023/6
N2 - Background: Low back pain is highly prevalent and the main cause of years lived with disability (YLDs). We present the most up-to-date global, regional, and national data on prevalence and YLDs for low back pain from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Methods: Population-based studies from 1980 to 2019 identified in a systematic review, international surveys, US medical claims data, and dataset contributions by collaborators were used to estimate the prevalence and YLDs for low back pain from 1990 to 2020, for 204 countries and territories. Low back pain was defined as pain between the 12th ribs and the gluteal folds that lasted a day or more; input data using alternative definitions were adjusted in a network meta-regression analysis. Nested Bayesian meta-regression models were used to estimate prevalence and YLDs by age, sex, year, and location. Prevalence was projected to 2050 by running a regression on prevalence rates using Socio-demographic Index as a predictor, then multiplying them by projected population estimates. Findings: In 2020, low back pain affected 619 million (95% uncertainty interval 554–694) people globally, with a projection of 843 million (759–933) prevalent cases by 2050. In 2020, the global age-standardised rate of YLDs was 832 per 100 000 (578–1070). Between 1990 and 2020, age-standardised rates of prevalence and YLDs decreased by 10·4% (10·9–10·0) and 10·5% (11·1–10·0), respectively. A total of 38·8% (28·7–47·0) of YLDs were attributed to occupational factors, smoking, and high BMI. Interpretation: Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased modestly over the past three decades, it is projected that globally in 2050, more than 800 million people will have low back pain. Challenges persist in obtaining primary country-level data on low back pain, and there is an urgent need for more high-quality, primary, country-level data on both prevalence and severity distributions to improve accuracy and monitor change. Funding: Bill and Melinda Gates Foundation.
AB - Background: Low back pain is highly prevalent and the main cause of years lived with disability (YLDs). We present the most up-to-date global, regional, and national data on prevalence and YLDs for low back pain from the Global Burden of Diseases, Injuries, and Risk Factors Study 2021. Methods: Population-based studies from 1980 to 2019 identified in a systematic review, international surveys, US medical claims data, and dataset contributions by collaborators were used to estimate the prevalence and YLDs for low back pain from 1990 to 2020, for 204 countries and territories. Low back pain was defined as pain between the 12th ribs and the gluteal folds that lasted a day or more; input data using alternative definitions were adjusted in a network meta-regression analysis. Nested Bayesian meta-regression models were used to estimate prevalence and YLDs by age, sex, year, and location. Prevalence was projected to 2050 by running a regression on prevalence rates using Socio-demographic Index as a predictor, then multiplying them by projected population estimates. Findings: In 2020, low back pain affected 619 million (95% uncertainty interval 554–694) people globally, with a projection of 843 million (759–933) prevalent cases by 2050. In 2020, the global age-standardised rate of YLDs was 832 per 100 000 (578–1070). Between 1990 and 2020, age-standardised rates of prevalence and YLDs decreased by 10·4% (10·9–10·0) and 10·5% (11·1–10·0), respectively. A total of 38·8% (28·7–47·0) of YLDs were attributed to occupational factors, smoking, and high BMI. Interpretation: Low back pain remains the leading cause of YLDs globally, and in 2020, there were more than half a billion prevalent cases of low back pain worldwide. While age-standardised rates have decreased modestly over the past three decades, it is projected that globally in 2050, more than 800 million people will have low back pain. Challenges persist in obtaining primary country-level data on low back pain, and there is an urgent need for more high-quality, primary, country-level data on both prevalence and severity distributions to improve accuracy and monitor change. Funding: Bill and Melinda Gates Foundation.
UR - http://www.scopus.com/inward/record.url?scp=85160104010&partnerID=8YFLogxK
U2 - 10.1016/S2665-9913(23)00098-X
DO - 10.1016/S2665-9913(23)00098-X
M3 - Article
AN - SCOPUS:85160104010
SN - 2665-9913
VL - 5
SP - e316-e329
JO - The Lancet Rheumatology
JF - The Lancet Rheumatology
IS - 6
ER -